Name
DOXACURIUM
Mode of Action
DOXACURIUM IS A BENZYLISOQUINOLINIUM COMPETITIVE NEUROMUSCULAR BLOCKER. THIS AGENTS ANAGONIZE THE NEUROTRANSMITTER ACTION OF ACETYLCHOLINE BY BINDING COMPETITIVELY WITH CHOLINERGIC RECEPTOR SITES ON THE MOTOR END-PLATE. IT MOST ADVANTAGEOUSLY IF MUSCLE TWITCH RESPONSE TO PERIPHERAL NERVE STIMULATION IS MONITERED TO ASSESS DEGREE OF MUSCLE RELAXATION.
Dosage
THE INITIAL DOSE ;- 50 MCG/KG/BODY WT I.V.. MAINTENANCE ;- 5-10 MCG/KG/BODY WT. DAILY.
Drug Group
[MUSCLE RELAXANT] , [NEUROMUSCULAR BLOCKING AGENT]
Cross Reaction
ENFLURANE, ISOFLURANE, HALOTHANE, AMINOGLYCOSIDES AND POLYMYXINS, LITHIUM, MAGNESIUM SALTS, PROCAINAMIDE AND QUINIDINE MAY ENHANCE THE NEUROMUSCULAR BLOCKING ACTION OF DOXACURIUM.
Drug Interaction
Drugs Side Effect
Drug Categories
Special Precaution
Drug Safety
Monograph